MVI 200

DRUG3 trials

Sponsors

Ferring Pharmaceuticals

Conditions

Cervical RipeningInduction of LaborReducing Time to Vaginal Delivery

Phase 2

Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor

CompletedNCT00828711

Ferring PharmaceuticalsCervical Ripening, Induction of Labor

Start: 2009-04-30End: 2009-12-31Updated: 2014-04-21

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

CompletedNCT01283022

Ferring PharmaceuticalsCervical Ripening, Induction of Labor

Start: 2011-05-31End: 2011-07-31Updated: 2014-04-14

Phase 3

Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery

CompletedNCT01127581

Ferring PharmaceuticalsCervical Ripening, Induction of Labor, Reducing Time to Vaginal Delivery

Start: 2010-09-30End: 2012-03-31Updated: 2014-05-01

Related Papers

Prediction of successful labor induction in persons with a low Bishop score using machine learning: Secondary analysis of two randomized controlled trials

Birth2022-12-219 citations

Optimising daytime deliveries when inducing labour using prostaglandin vaginal inserts.

2015-03-167 citations

Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial.

2013-08-0165 citations

Misoprostol vaginal insert for successful labor induction: a randomized controlled trial.

2011-03-0126 citations